公开(公告)号：US20150011555A1

公开(公告)日：2015-01-08

申请号：US14371593

申请日：2013-01-11

Applicant: NOVARTIS AG

Inventor： Catherine Leblanc ,  Stephen Carl McKeown ,  Anett Perlberg ,  Nicola Tufilli

IPC: C07D471/04

CPC classification number: C07D471/04

Abstract: The invention relates to salts of (7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid which are useful for treating diseases affected by the activation of the IP receptor, pharmaceutical compositions that contain the salts and processes for preparing the salts are also described.

Abstract translation: 本发明涉及（7-（2,3-二 - 对甲苯基-7,8-二氢吡啶并[2,3-b]吡嗪-5（6H） - 基）庚酸的盐，其可用于治疗受影响的疾病 通过IP受体的激活，还描述了含有盐的药物组合物和用于制备盐的方法。